|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ETF D: Tackling the Value in CER—Analyzing Cost of Care for Value-Based Decisions |
- Understand how CER is used in making decisions on medical necessity for populations and subpopulations
- Strategies for generating evidence when randomized clinical trials are not possible
- The intersection of CER and personalized therapies for the next frontier in value-based care
|
|
Joe V. Selby, MD, MPH
Executive Director
Patient-Centered Outcomes Research Institute (PCORI)

View Biography
|
|
Mark Gibson
Director, Center for Evidence-Based Policy
Oregon Health and Science University

View Biography
|
|
Robert McDonough, MD, JD
Head, Clinical Policy Research & Development
Aetna

View Biography
|
|
Felix W. Frueh, PhD
President, Medco Research Institute
Medco Health Solutions, Inc.

View Biography
|
| Moderator: |
|
J. Lyle Bootman, PhD
Senior Vice President for Health Sciences
Dean, College of Pharmacy
The University of Arizona

View Biography
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|